Comparison of the effectiveness of cervical cytology versus high-risk HPV DNA tests in early detection of pre-cancerous cervical lesions: A Systematic Review
Vol. 6 No. 7 (2024), Systematic Review
Vol. 6 No. 7 (2024)

Comparison of the effectiveness of cervical cytology versus high-risk HPV DNA tests in early detection of pre-cancerous cervical lesions: A Systematic Review

Systematic Review
https://doi.org/10.36557/2674-8169.2024v6n7p317-325
Published 2024-07-03
Pedro Henrique Enricone Coimbra
Residente de Ginecologia e Obstetrícia na Associação de Proteção à Maternidade e a Infância de Cuiabá
https://orcid.org/0009-0005-2225-4073
José Lucas Moura Vasconcelos
UniFG Guanambi
Amanda Borges Barbero
UNIVAG
https://orcid.org/0009-0005-5744-386X
Andreus Cristhian Linhares Andrade
Universidade de Cuiabá - UNIC
https://orcid.org/0000-0003-0436-2167
Bárbara de Oliveira Baptista Savariego
Universidade Nilton Lins
https://orcid.org/0009-0006-1496-8081
Bianca Mayara Sampaio de Araújo
Universidade Nilton Lins
https://orcid.org/0009-0007-8491-1109
Daniel Antonio de Alcantara Machado
Universidade de Cuiaba - UNIC
https://orcid.org/0009-0005-9384-1929
Gustavo Henrique da Silva Araujo
Unidep - Centro Universitário de Pato Branco
https://orcid.org/0009-0007-2882-7025
Helem da Silva e Silva Pimentel
Unifamaz
https://orcid.org/0009-0003-3565-5525
Isabela Vasconcelos Ramos Andrade
Faculdade da Saúde e Ecologia Humana - FASEH
https://orcid.org/0000-0003-3321-5633
Julia Maria Prestes Capatto
Universidade de Cuiabá- UNIC
https://orcid.org/0009-0003-8055-7086
Karine Sarmento Santos
UNIFG Brumado
https://orcid.org/0009-0005-8795-2358
Karla Romero Santos
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0005-1539-4422
Lais Codeco de Souza
Faminas Muriaé
https://orcid.org/0009-0007-3332-1766
Luana Cruz Nunes Godinho
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0000-3258-5849
Maria Tereza Barbieri Fagundes
Universidade Anhembi Morumbi - UAM
https://orcid.org/0009-0000-8340-6898
Sabrini Bernardi
Faseh
https://orcid.org/0009-0004-1318-4862
Thaís da Silva Torres
UNIFG Brumado
https://orcid.org/0009-0007-6684-5267
Yasmin Carvalho de Paula Freitas
Universidade Nilton Lins
https://orcid.org/0009-0008-4192-7407
PDF (Português (Brasil))

Keywords

Cervical Cytology, HPV DNA Testing, Cervical Cancer, Early Detection.

How to Cite

Coimbra , P. H. E., Vasconcelos, J. L. M., Barbero , A. B., Andrade, A. C. L., Savariego, B. de O. B., Araújo, B. M. S. de, Machado , D. A. de A., Araujo , G. H. da S., Pimentel, H. da S. e S., Andrade, I. V. R., Capatto, J. M. P., Santos, K. S., Santos , K. R., Souza, L. C. de, Godinho , L. C. N., Fagundes, M. T. B., Bernardi , S., Torres, T. da S., & Freitas, Y. C. de P. (2024). Comparison of the effectiveness of cervical cytology versus high-risk HPV DNA tests in early detection of pre-cancerous cervical lesions: A Systematic Review. Brazilian Journal of Implantology and Health Sciences, 6(7), 317–325. https://doi.org/10.36557/2674-8169.2024v6n7p317-325
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

This systematic review investigated the comparative effectiveness of cervical cytology (Papanicolaou) versus high-risk HPV DNA tests in the early detection of pre-cancerous cervical lesions. Methodology included electronic database search, careful study selection, and result analysis. Reviewed studies provided diverse insights, highlighting the superior sensitivity of HPV DNA tests but also concerns regarding false positives and costs. The decision regarding screening method should consider individual and contextual factors. It is concluded that there is no one-size-fits-all approach to cervical cancer screening, emphasizing the importance of individualized decisions and ongoing research to enhance screening services.

https://doi.org/10.36557/2674-8169.2024v6n7p317-325
PDF (Português (Brasil))

References

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., ... & Bergeron, C. (2012). Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine, 30(Suppl 5), F88-F99.

Bulkmans, N. W., Rozendaal, L., Snijders, P. J., Voorhorst, F. J., Boeke, A. J., Zandwijken, G. R., ... & Meijer, C. J. (2004). POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. International journal of cancer, 110(1), 94-101.

Cuzick, J., Clavel, C., Petry, K. U., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., ... & Szarewski, A. (2006). Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International journal of cancer, 119(5), 1095-1101.

Kitchener, H. C., Almonte, M., Thomson, C., Wheeler, P., Sargent, A., Stoykova, B., ... & Castle, P. E. (2009). HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. The Lancet Oncology, 10(7), 672-682.

Mayrand, M. H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., ... & Franco, E. L. (2007). Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal of Medicine, 357(16), 1579-1588.

Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., ... & Dillner, J. (2009). Human papillomavirus and Papanicolaou tests to screen for cervical cancer. New England Journal of Medicine, 357(16), 1589-1597.

Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J., Arbyn, M., ... & Segnan, N. (2014). Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The Lancet, 383(9916), 524-532.

Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Dalla Palma, P., Del Mistro, A., ... & Zorzi, M. (2010). Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. The Lancet Oncology, 11(3), 249-257.

Ronco, G., Segnan, N., Giorgi-Rossi, P., Zappa, M., Casadei, G. P., Carozzi, F., ... & Cuzick, J. (2006). Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. Journal of the National Cancer Institute, 98(11), 765-774.

Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., Castle, P. E., ... & Burk, R. D. (2011). Human papillomavirus testing in the prevention of cervical cancer. Journal of the National Cancer Institute, 103(5), 368-383.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Pedro Henrique Enricone Coimbra , José Lucas Moura Vasconcelos, Amanda Borges Barbero , Andreus Cristhian Linhares Andrade, Bárbara de Oliveira Baptista Savariego, Bianca Mayara Sampaio de Araújo, Daniel Antonio de Alcantara Machado , Gustavo Henrique da Silva Araujo , Helem da Silva e Silva Pimentel, Isabela Vasconcelos Ramos Andrade, Julia Maria Prestes Capatto, Karine Sarmento Santos, Karla Romero Santos , Lais Codeco de Souza, Luana Cruz Nunes Godinho , Maria Tereza Barbieri Fagundes, Sabrini Bernardi , Thaís da Silva Torres, Yasmin Carvalho de Paula Freitas